Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Understanding lung injury from ozone exposure

Official title: Activated Macrophages and Ozone Toxicity II

Run by Rutgers, The State University of New Jersey · NCT05794087 · Data updated 2026-11-12

This study is testing how breathing in ozone affects lung injury by looking at immune cell activity in the mucus of people who will exercise after being exposed to both clean air and ozone.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment120 (estimated)
SponsorRutgers, The State University of New Jersey
Academic / other
Locations1 site (Piscataway, New Jersey)
StatusRecruiting
StartedFebruary 7, 2023
Main results expectedJune 1, 2027
Study endsJune 1, 2027
Registry record updatedDecember 17, 2025
Trial IDNCT05794087 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy individuals who are vaccinated against COVID-19 and can produce sputum samples.

Probably not a fit

Patients with cardiovascular or respiratory diseases, recent respiratory symptoms, or other specified health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate how ozone exposure affects lung injury by analyzing macrophage activity in sputum samples. Participants will undergo two exposure sessions, one to filtered air and another to 0.2 ppm ozone, with at least two weeks between sessions. Each session will involve physical activity on an exercise bicycle, and follow-up visits will include sputum, blood, and exhaled breath sample collections for analysis. The study is conducted at the Rutgers EOHSI clinical center in Piscataway, NJ.

Why it matters

Potential benefit: If successful, this study could lead to a better understanding of lung injury mechanisms, potentially informing treatment strategies for those affected by air pollution.

How similar studies have gone: While studies on air pollution and lung injury exist, this specific approach focusing on macrophage activity in response to ozone exposure is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Exclusion Criteria:

* Cardiovascular disease
* Respiratory disease
* Recent (within 4 weeks) respiratory or COVID-19 symptoms
* Diabetes
* Pregnancy
* HIV Infection
* History of smoking within the past 5 years.
* Orthopedic or rheumatologic conditions which would interfere with cycle use
* Inability to produce a sputum plug at screening
* Daily use of antioxidant supplements, excluding those in a multivitamin. These supplements include Vitamin C or E, selenium, beta-carotene, lycopene, lutein, zeaxanthin and ginkgo biloba. Supplements taken less frequently but at least once a week will be reviewed by the principal investigator for eligibility determination.

Where it's running

  • Rutgers - EOHSI
    Piscataway, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.